Hester Biosciences Ltd

NSE: HESTERBIO · BSE: 524669 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹2,182.90
Market cap: ₹1,857 Cr
Revenue (annual): ₹332.6 Cr
Net profit (annual): ₹55.64 Cr
P/E (TTM): 13.6×Sector 50.4×
Promoter holding: 53.73%+0.00% QoQ
FII holding: 0.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Reclassification 1 Financial Results 1 Earnings Call 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

4 Sep 2026 13:30 IST BSE

Promoter Reclassification

Hester Biosciences Promoter Reclassification

Hester Biosciences Limited received shareholder approval to reclassify Mr. Ravin Gandhi and Ms. Bela Gandhi from the 'Promoter' category to the 'Public' category.

Read the filing ↗

4 Sep 2026 10:28 IST BSE

Annual General Meeting

Hester Biosciences Annual General Meeting

Hester Biosciences Limited shareholders approved the reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from 'Promoter' to 'Public' category via postal ballot.

Read the filing ↗

30 Jul 2026 16:46 IST NSE

Earnings Call

Hester Biosciences Earnings Call Transcript: Key Takeaways

Hester Biosciences delivered strong standalone Q1 growth with revenues up 14% and profit up 88%. Consolidated profit surged 459% due to an INR 853.49 million exceptional gain from a loan amendment.

Open call summary → Read the filing ↗

30 Jul 2026 11:18 IST BSE

Financial Results

Hester Biosciences Q1 FY27 Results: Net Profit ₹96.7 Cr, Up 459.0% YoY

Hester Biosciences Ltd reported revenue from operations of ₹77.2 Cr (-8.2% YoY) and net profit of ₹96.7 Cr (+459.0% YoY) for Q1 FY27.

Key figure: Net profit ₹96.7 Cr · +459.0% YoY

Open full results → Read the filing ↗